CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...